Cargando…

Analysis of Tumor Angiogenesis and Immune Microenvironment in Non-Functional Pituitary Endocrine Tumors

Cavernous sinus (CS) invasion is an aggressive behavior exhibited by pituitary neuroendocrine tumors (PitNETs). The cause of CS invasion in PitNETs has not been fully elucidated. The tumor immune microenvironment, known to promote aggressive behavior in various types of tumors, has not been examined...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Mizuto, Tamura, Ryota, Tamura, Haruka, Mase, Taro, Kosugi, Kenzo, Morimoto, Yukina, Yoshida, Kazunari, Toda, Masahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572068/ https://www.ncbi.nlm.nih.gov/pubmed/31100921 http://dx.doi.org/10.3390/jcm8050695

Ejemplares similares

Relationship between pneumatization of lateral recess in the sphenoid sinus and removal of cavernous sinus invasion in pituitary adenomas by endoscopic endonasal surgery
por: Kosugi, Kenzo, et al.
Publicado: (2019)

A Pilot Study of the Adverse Events Caused by the Combined Use of Bevacizumab and Vascular Endothelial Growth Factor Receptor-Targeted Vaccination for Patients with a Malignant Glioma
por: Tamura, Ryota, et al.
Publicado: (2020)

Long-Term Clinical Outcome of First Recurrence Skull Base Meningiomas
por: Kuranari, Yuki, et al.
Publicado: (2019)

Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Patients With Meningiomas
por: Kuranari, Yuki, et al.
Publicado: (2020)

Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series
por: Tamura, Ryota, et al.
Publicado: (2020)

Correction to: Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series
por: Tamura, Ryota, et al.
Publicado: (2020)

Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2
por: Tamura, Ryota, et al.
Publicado: (2020)

A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2
por: Tamura, Ryota, et al.
Publicado: (2019)

Alterations of the tumor microenvironment in glioblastoma following radiation and temozolomide with or without bevacizumab
por: Tamura, Ryota, et al.
Publicado: (2020)

IMT-02 VEGF RECEPTORS EXPRESSION AND REPORT OF CLINICAL TRIAL OF PEPTIDE VACCINE IN SKULL BASE CHORDOMA
por: Morimoto, Yukina, et al.
Publicado: (2019)

Persistent restoration to the immunosupportive tumor microenvironment in glioblastoma by bevacizumab
por: Tamura, Ryota, et al.
Publicado: (2018)

Gene therapy using genome‐edited iPS cells for targeting malignant glioma
por: Tamura, Ryota, et al.
Publicado: (2022)

A Pilot Study of Vaccine Therapy with Multiple Glioma Oncoantigen/Glioma Angiogenesis-Associated Antigen Peptides for Patients with Recurrent/Progressive High-Grade Glioma
por: Kikuchi, Ryogo, et al.
Publicado: (2019)

GH-Producing Pituitary Adenoma and Concomitant Rathke's Cleft Cyst: A Case Report and Short Review
por: Tamura, Ryota, et al.
Publicado: (2015)

Volumetric measurement of paranasal sinuses and its clinical significance in pituitary neuroendocrine tumors operated using an endoscopic endonasal approach
por: Nakaya, Masato, et al.
Publicado: (2023)

GCT-51. IMMUNE CHECKPOINT MOLECULES AND TUMOR INFILTRATING LEUKOCYTES IN THE TUMOR MICROENVIRONMENT ARE ASSOCIATED WITH THE GROWTH OF INTRACRANIAL GERMINOMAS
por: Nishimoto, Masaaki, et al.
Publicado: (2020)

A case of acute subdural hematoma due to bleeding from metastatic chondrosarcoma of the skull
por: Kosugi, Kenzo, et al.
Publicado: (2017)

Histopathological Investigation of Dura-like Membrane in Vestibular Schwannomas
por: Oishi, Yumiko, et al.
Publicado: (2021)

Neuroprotective Effects of Genome-Edited Human iPS Cell-Derived Neural Stem/Progenitor Cells on Traumatic Brain Injury
por: Imai, Ryotaro, et al.
Publicado: (2023)

“Paradoxical” findings of tumor vascularity and oxygenation in recurrent glioblastomas refractory to bevacizumab
por: Yamamoto, Yohei, et al.
Publicado: (2017)

Severe headache in a patient with meningioma showing extensive dural tail correlates with IgG4-positive plasma cells and eosinophils: A case report and review of literature
por: Kuranari, Yuki, et al.
Publicado: (2018)

Histopathological Analysis of Tumor Microenvironment and Angiogenesis in Pheochromocytoma
por: Gao, Xin, et al.
Publicado: (2020)

Visualization of spatiotemporal dynamics of human glioma stem cell invasion
por: Tamura, Ryota, et al.
Publicado: (2019)

Isolated Pituitary Tuberculoma
por: Saito, Katsuya, et al.
Publicado: (2014)

Posture-induced changes in the vessels of the head and neck: evaluation using conventional supine CT and upright CT
por: Kosugi, Kenzo, et al.
Publicado: (2020)

The role of microenvironment in tumor angiogenesis
por: Jiang, Xianjie, et al.
Publicado: (2020)

The role of the tumour microenvironment in the angiogenesis of pituitary tumours
por: Marques, Pedro, et al.
Publicado: (2020)

Giant cell tumors of the clivus: Case report and literature review
por: Shibao, Shunsuke, et al.
Publicado: (2015)

A Critical Overview of Targeted Therapies for Vestibular Schwannoma
por: Tamura, Ryota, et al.
Publicado: (2022)

Targeting the Tumor Microenvironment: Focus on Angiogenesis
por: Fan, Fengjuan, et al.
Publicado: (2012)

Glycosylation in the Tumor Microenvironment: Implications for Tumor Angiogenesis and Metastasis
por: Brown Chandler, Kevin, et al.
Publicado: (2019)

The Microenvironment of Pituitary Tumors—Biological and Therapeutic Implications
por: Ilie, Mirela Diana, et al.
Publicado: (2019)

Cathepsin D Inhibits Angiogenesis in Pituitary Neuroendocrine Tumors
por: Fujiwara, Ren, et al.
Publicado: (2022)

Historic Overview of Genetic Engineering Technologies for Human Gene Therapy
por: TAMURA1, Ryota, et al.
Publicado: (2020)

Myeloid Cells in the Tumor Microenvironment: Modulation of Tumor Angiogenesis and Tumor Inflammation
por: Schmid, Michael C., et al.
Publicado: (2010)

Imaging of pituitary tumors: an update with the 5th WHO Classifications—part 1. Pituitary neuroendocrine tumor (PitNET)/pituitary adenoma
por: Tsukamoto, Taro, et al.
Publicado: (2023)

Oxidative stress in pituitary neuroendocrine tumors: Affecting the tumor microenvironment and becoming a new target for pituitary neuroendocrine tumor therapy
por: Zhou, Yuhang, et al.
Publicado: (2023)

Correlation between genotype and phenotype with special attention to hearing in 14 Japanese cases of NF2-related schwannomatosis
por: Oishi, Naoki, et al.
Publicado: (2023)

Correction to: Imaging of pituitary tumors: an update with the 5th WHO Classifications—part 1. Pituitary neuroendocrine tumor (PitNET)/pituitary adenoma
por: Tsukamoto, Taro, et al.
Publicado: (2023)

Drug Repositioning for Refractory Benign Tumors of the Central Nervous System
por: Tamura, Ryota
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rckoml7fjfk6ganbpbjqv2k3dm